KNSA icon

Kiniksa Pharmaceuticals
KNSA

Overview Fund Trends Analyst Outlook Journalist POV

104 hedge funds and large institutions have $537M invested in Kiniksa Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

18% less call options, than puts

Call options by funds: $4.96M | Put options by funds: $6.08M

19% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 21

Holders
104
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.96M
Puts
$6.08M
Net Calls
Net Calls Change

Top Buyers

1
+$8.07M
2
+$7.4M
3
+$6.76M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.94M
5
Millennium Management
Millennium Management
New York
+$4.11M

Top Sellers

1
-$18.5M
2
-$7.87M
3
-$6.24M
4
ACH
ArrowMark Colorado Holdings
Colorado
-$5.29M
5
OCA
Octagon Capital Advisors
New York
-$5.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
101
$1K
102
$1K
103
$288
104
–
105
–
106
–
107
–
108
–
109
–
110
–
111
–
112
–
113
–
114
–
115
–
116
–
117
–
118
–
119
–
120
–
121
–
122
–
123
–
124
–
1 2 3 4
5